ONVO - Organovo

ONVO valuation $436.35 million

Stock Price

Change: ↓ -0.44 (-7.3333%)
Last Update: 2014-10-13T07:32:54-04:00
Shares Outstanding: 78,479,800
Industry: Medical Diagnostics & Research
Website Investor Relations

Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications.

The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.

The Company plans to market the first product of a planned portfolio offering, 3D Human Liver Tissue for use in Toxicology and other preclinical drug testing prior to the end of 2014, and remains on track to bring this breakthrough technology to customers. 

In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others.

Stock Price Data

Open: 5.86 Previous Close: 6.00
High: 5.98 Low: 5.53
Bid: 0.00 Ask: 0.00

Bid Size: 0 Ask Size: 0
Raw Bid Size: 0 Raw Ask Size: 0
Trade Volume: 2 Share Volume: 963448
Last Trade Date: 2014-10-10 Last Trade Time: 16:00:05-04:00
Vwap: 5.75971205 EPS: -0.37

Fundamental Data

PE ratio: PB ratio: 9.929
Beta: 0.191382

52 Week High: 13.65 52 Week Low: 5.12
52 Week High Vwap: 12.9401 52 Week Low Vwap: 5.3507
52 Week High Volume: 31028858 52 Week Low Volume: 345334
52 Week Avg Volume: 2790269
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
A Agilent Technologies Inc. 53.64
DGX Quest Diagnostics Inc. 58.37
TMO Thermo Fisher Scientific 116.47
PKI PerkinElmer Inc. 41.18
IRWD Ironwood Pharmaceuticals Inc. 11.97
RGDX Response Genetics Inc. 0.63
SPEX Spherix Incorporated 0.96
ICLR ICON plc 55.12
QGEN Qiagen N.V. 21.80
PRXL PAREXEL International Corporation 58.19